Pro Medicus (FRA:PMC) ROE % Adjusted to Book Value : 0.79% (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Pro Medicus ROE % Adjusted to Book Value?

Pro Medicus's ROE % for the quarter that ended in Dec. 2023 was 48.45%. Pro Medicus's PB Ratio for the quarter that ended in Dec. 2023 was 61.43. Pro Medicus's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was 0.79%.

Pro Medicus ROE % Adjusted to Book Value Historical Data

The historical data trend for Pro Medicus's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pro Medicus ROE % Adjusted to Book Value Chart

Pro Medicus Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

0.75

0.92

0.59

1.16

1.03

Pro Medicus Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															0.67	1.16	1.01	1.09	0.79

Competitive Comparison of Pro Medicus's ROE % Adjusted to Book Value

For the Health Information Services subindustry, Pro Medicus's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pro Medicus's ROE % Adjusted to Book Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pro Medicus's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Pro Medicus's ROE % Adjusted to Book Value falls into.

Pro Medicus ROE % Adjusted to Book Value Calculation

Pro Medicus's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	48.92%	/	47.63
	=	1.03%

Pro Medicus's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	48.45%	/	61.43
	=	0.79%

Pro Medicus ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Pro Medicus's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Pro Medicus (FRA:PMC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pro Medicus Ltd (FRA:PMC) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

PMCUF:USA PME:Australia

Address

450 Swan Street, Richmond, Melbourne, VIC, AUS, 3121

Website

https://www.promed.com.au

Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are U.S. private academic hospitals. In fiscal 2022, Pro Medicus earned 79% of revenue in North America, 16% from Australia, and the remaining 6% in Europe.

Pro Medicus (FRA:PMC) Headlines

From GuruFocus

PharMerica Corp. Reports Operating Results (10-Q)

By gurufocus 10qk • 08-05-2010

PharMerica Corp. Reports Operating Results (10-Q)

By gurufocus 10qk • 11-04-2010

Weekly CFO Buys Highlight: PMC, ZBB

By gurujk gurujk • 06-25-2012

PharMerica Corp. (PMC) CEO Gregory S Weishar buys 25,000 Shares

By GuruFocus Research GuruFocus Editor • 11-16-2009

PharMerica Corp. (PMC) CEO Gregory S Weishar buys 81,000 Shares

By GuruFocus Research GuruFocus Editor • 08-13-2010